Rachmiel Levine-Arthur Riggs Symposium 2025 Resource Hub –
Welcome to our resource hub for Rachmiel Levine-Arthur Riggs Diabetes Research Symposium! This is a one-stop-shop for all your Rachmiel Arthur Levine-Riggs needs. We will be updating the resource hub daily, so check back in for the latest on this fantastic meeting.
Useful Conference Links
Daily Coverage
Top Highlights
- Dr. Witkowski delivers an opening address highlighting the evolution of islet transplantation treatments
- Tegoprubart as a less toxic alternative for immunosuppression in islet allogenic transplantation
- Chemically induced pluripotent stem cell-derived islet transplantation as the future of T1D cures
- Dr. Michael Rickels on stem cell-derived islets and Vertex’s VX-880 (zimisclecel)
- Dr. Carmella Evans-Molina’s “Christmas Wish List” for the future of T1D research
- Rachmiel Levine Award Lecture: Yale’s Dr. Kevan Herold on Tzield and T1D cures without systemic immunosuppression
- Circulating extracellular vesicles as potential mediators (and therapeutic targets) for early ß-cell injury in T1D
- RNA splicing as an overlooked mechanism of ß-cell failure
- Immune intolerance in T1D as a defect in the functional balance between T cell subtypes
- Using CAR Treg cells to prevent islet transplantation rejection in T1D
- Modifying the donor, rather than the recipient: Islet xenotransplantation as a potential cure for T1D
- Extraislet beta cells loss in T1D highlights importance of early screening and intervention
- Quantifying individual T1D risk and response to disease-modifying therapies: Risk prediction model options and the quantitative response metric
- Prof. Anette-Gabriele Ziegler shares results and insights from the POInT oral insulin T1D primary prevention trial
- Arthur Riggs Award Lecture: Dr. Alvin Powers on diabetes heterogeneity and advances in islet research
- The evolution of insulins: What’s coming next to mimic beta cell activity?